Question About 'Gemcitabine bladder instillation dosing'

How do you administer gemcitabine to a UTI patient?

Instill BCG, Mitomycin, or Gemcitabine per gravity flow or by gentle push instillation. Administer Docetaxel irrigation into the bladder by slow push or gravity flow through a catheter over a 5-minute period. (Barlow, 2009) Assess the patient for pain.

https://www.suna.org/resources/intravesicalMedAdminStatement.pdf


How often do you have to take gemcitabine?

Maintenance: monthly for 10 doses, starting 6 weeks after end of induction (i.e. at 3 months) After 1 to 2 hours unclamp the catheter and allow the urine and gemcitabine to drain into the drainage bag After one additional hour of diuresis, remove catheter

http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Genitourinary/GUBGEM_Protocol.pdf


How many mg of gemcitabine are in a 200mg vial?

GEMZAR(gemcitabine) is a sterile white to off-white lyophilized powder and available as 200 mg and 1 g single-dose vials for intravenous use only. Each 200mg vial contains200 mggemcitabine(equivalent to 227.7 mg gemcitabine hydrochloride),200 mg mannitol and 12.5 mg sodium acetate.

https://pi.lilly.com/us/gemzar.pdf


How is gemcitabine used to treat bladder cancer?

Gemcitabine is put directly into your bladder through a fine tube (catheter) to treat the entire lining of your bladder. This method is known as ‘instilling’. The treatment usually involves coming to hospital once a week for six weeks as an outpatient.

https://www.wsh.nhs.uk/CMS-Documents/Patient-leaflets/UrologyDepartment/6055-1-Gemcitabine-for-Bladder-Cancer.pdf


pdf for "gemcitabine bladder instillation dosing".(Page 1 of about 18 results)

"gemcitabine bladder instillation dosing"


pdf ico  Gemcitabine Bladder Therapy

2. Your nurse will then put a small amount of Gemcitabine fluid into your bladder through the catheter. This is called an instillation. 3. The nurse removes the catheter. You then hold the fluid in your bladder for 1 hour. This may be hard for some patients. Try to hold it as long as possible (but not longer than 2 hours). 4. You can go home ...

pdf ico  Chemotherapy Bladder Instillation - Intermountain Healthcare

Chemotherapy [kee-moe-THAIR-uh-pee] bladder instillation [in-stil-LAY-shun] is a treatment for bladder cancer. During treatment, liquid chemotherapy medication is placed into your bladder through a catheter [CATH-eh-ter] (a thin, flexible tube). The medication kills cancer cells on the bladder wall and may prevent or delay their return. The usual

pdf ico  Cisplatin and Gemcitabine (bladder) - NHS England

Gemcitabine is administered in 250-500mL sodium chloride 0.9% over 30 minutes. Cisplatin is administered in 500mL sodium chloride 0.9% over 60 minutes following the pre and post hydration protocol below. Infusion Fluid & Additives Volume Infusion Time Sodium Chloride 0.9% 1000mL 60 minutes Mannitol 20% 200mL 10 minutes OR

pdf ico  Gentamicin Bladder Instillations: Instructions for ... - Michigan …

into bladder. 2. Disconnect catheter from bag or unplug catheter and allow all the u rine to drain from the bladder. 3. Once bladder is empty, attach syringe (with Gentamicin in it already) to end of the catheter and slowly push solution into bladder. 4. Once syringe is empty, leave it attached to the catheter for ____ minutes.

pdf ico  MITOMYCIN Bladder Instillation Instructions

Mitomycin (my-toe-MY-sin) is a drug used to treat bladder cancer. It is a clear blue or purple liquid that is given through a small tube into the bladder. Do not drink liquids for 2 hours before your treatment so your bladder will be empty. Your doctor or nurse will insert a catheter (small tube) into your bladder and drain out any urine.

pdf ico  Cisplatin and Gemcitabine Bladder Cancer: Split dose

Gemcitabine: refer to local guidelines for management extravasation Dosing in renal and hepatic impairment: Renal impairment: Cisplatin CrCL (mL/min) Dose 40 to 60 mL/min 100% Below 40 Switch to carboplatin Gemcitabine: CrCl (mL/min) Dose >31 1000mg/m2 (100% dose) <30 Omit

pdf ico  Your Guide to Bladder Instillation Treatment - Alberta …

Superficial bladder cancer can be treated by putting medications directly into the bladder. This is called bladder instillation or intravesical therapy. The medications work on the tumour cells on the inner lining of the bladder and help keep the cancer from coming back (recurrence). It is a treatment often used after surgery. There are two ...

pdf ico  Bladder Instillation Patient Teaching Sheet

To flush your bladder and to minimize side effects drink at least 8-12 cups of liquid (i.e. water or fruit juice) a day for one week following your treatment and urinate frequently. This may need to be adjusted by your doctor. Avoid tea, coffee, alcohol, and cola drinks as they may increase bladder irritation. Can I have sex after my treatment?

pdf ico  Intravesical Gemcitabine: State of the Art - European Urology

bladder cancers, yielding response rates of 27–38% [13–14]. Gemcitabine has a molecular weight of 299 D, lower than that of commonly used intravesical chemotherapeutic agents such as mitomycin C (389 D) and doxorubicin (589 D). Its lower molecular weight may enable gemcitabine to penetrate the bladder mucosa with beneficial effects in the

pdf ico  Intravesical Administration of Therapeutic Medication for the …

bladder spasms. 6. Empty the bladder prior to instillation of medication for maximum medication concentration in bladder. B. Documentation: 1. All the above. 2. Also, document the lot number, expiration date and post procedure instructions and teaching (both verbal and written). In addition, document

pdf ico  Evidence-based Guidelines for Best Practice in …

Intravesical instillation – March 2015 7 Introduction Cancer of the urinary bladder Bladder cancer is the most common malignant tumour of the urinary tract, with an EU incidence of 27 and 6 per 100,000 in men and women, respectively. Smoking is the single most important risk factor and is implicated in 50% of cases. Occupational exposure

pdf ico  Reference ID: 3503046 - Food and Drug Administration

Patients with a known hypersensitivity to gemcitabine (4) WARNINGS AND PRECAUTIONS -----­ • Schedule-dependent toxicity: Increased toxicity with infusion time ... Weeks 1-8: weekly dosing for the first 7 weeks followed by one week rest. • After week 8: weekly dosing on Days 1, 8, and 15 of 28-day cycles. Dose Modifications

pdf ico  Chemotherapy Protocol BLADDER CISPLATIN (35) …

Bladder-Cisplatin (35)-Gemcitabine Coding (OPCS) Procurement – X70.5 Delivery – X72.1 & X72.4 References 1. Hussain SA, Stocken DD, Riley P et al. A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21 day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer 2004; 91 (5 ...

pdf ico  BC Cancer Protocol Summary for Intravesical Therapy for Non …

carcinoma of the bladder: a phase I and pharmacokinetic study. J Clin Oncol 2003;21(4):697-703. 6. Messing E, Tangen C, Lerner S, et al. Effect of intravesical instillation of gemcitabine vs. saline immediately following resection of suspected low-grade non-muscle invasive bladder cancer on tumour recurrence. JAMA 2018;319:1880-8. 7.

pdf ico  BC Cancer Protocol Summary for Intravesical Therapy for Non …

Diluted with normal saline up to 45 mL before instillation. Instillation into bladder via catheter. Clamp or plug foley ... 3. Steinberg RL, Thomas LJ, O'Donnell MA, Nepple KG. Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2015;1(1):65-72.

pdf ico  HIGHLIGHTS OF PRESCRIBING INFORMATION ... - Eli Lilly and …

GEMZAR (gemcitabine)for injection, for intravenous use Initial U.S. Approval: 1996-----RECENT MAJOR CHANGES----- Warnings and Precautions, Hemolytic Uremic Syndrome (5.4) 5/2019 ... • Weeks 1to 8: weekly dosing for the first 7 weeks followed by one week rest. • After week 8: weekly dosing on Days 1, 8, and 15 of each 28-day cycle. ...

pdf ico  HIGHLIGHTS OF PRESCRIBING INFORMATION

Patients with a known hypersensitivity to gemcitabine. (4) ----- • Schedule-Dependent Toxicity: Increased toxicity with infusion time greater than 60 minutes or dosing more frequently than once weekly. (5.1) • Myelosuppression: Monitor for myelosuppression prior to each cycle and reduce or withhold dose for severe myelosuppression. (5.2, 5.7)

pdf ico  PATIENT INFORMATION …